miRNA
6
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Investigation of miRNA Expression Profiles in Human Degenerated Intervertebral Disc Tissues
Circulating microRNAs and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA
miRNA Biomarkers in Multiple Sclerosis
Interplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery Disease
The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment